Liu N F, Yu Z, Luo Y, Sun D
Department of Plastic and Reconstructive Surgery, Lymphology Center, Shanghai Ninth Peoples Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lymphology. 2017;50(1):9-15.
Primary lymphedema is clinically and genetically heterogeneous with germline mutations identified in approximately 20 primary lymphedema genes. The lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) gene, also known as cell-surface retention sequence binding protein-1 (CRSBP-1), encodes the major hyaluronan receptor in lymphatic endothelia and is one of the most specific lymphatic vessel markers. However, the role of this lymphatic endothelial specific protein in the development of the lymphatic system and lymphatic diseases remains unclear. Here, we report a missense mutation c.18C>G (p.S6R) in exon 1 within the N-terminal extension domain (outside the hyaluronan binding region) of LYVE-1 in three generations of an inherited lymphedema family with or without clinical symptoms. Lymphatic imaging revealed a partial, weak and delayed enhancement of tortuous lymph collectors in the distal part of the lymphedematous lower limb. Our findings revealed that LYVE-1/CRSBP-1 mutation in primary lymphedema cases is connected with both structural and functional lymphatic defects.
原发性淋巴水肿在临床和遗传上具有异质性,在大约20个原发性淋巴水肿基因中发现了种系突变。淋巴管内皮透明质酸受体-1(LYVE-1)基因,也称为细胞表面保留序列结合蛋白-1(CRSBP-1),编码淋巴管内皮中的主要透明质酸受体,是最特异的淋巴管标志物之一。然而,这种淋巴管内皮特异性蛋白在淋巴系统发育和淋巴疾病中的作用仍不清楚。在此,我们报告了一个遗传性淋巴水肿家族三代人中LYVE-1的N端延伸结构域(在透明质酸结合区域之外)第1外显子中的一个错义突变c.18C>G(p.S6R),该家族有或无临床症状。淋巴成像显示,在淋巴水肿下肢远端,迂曲的淋巴管有部分、微弱和延迟的强化。我们的研究结果表明,原发性淋巴水肿病例中的LYVE-1/CRSBP-1突变与淋巴管的结构和功能缺陷均有关。